Protective microglia subtype offers potential therapeutic pathway in Alzheimer’s disease

November 5, 2025

In Alzheimer’s disease—the leading cause of dementia—microglia, the brain’s immune defenders, can act as both protectors and aggressors, shaping how the disease progresses.

FDA approves once-daily Idvynso tablet for treating HIV
The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA
Dietary fats shape pancreatic cancer risk via ferroptosis
For decades, the relationship between fat and cancer has been treated as a question of quantity: Eat less fat, reduce your risk of developing cancer. But new research published April 29 in Cancer Discovery shows that for pancreatic cancer, the type of fat you consume matters more than the amount.
FDA recalls several Ghirardelli powdered beverages over potential contamination
Several powdered beverage mixes by Ghirardelli Chocolate Company are being recalled due to possible concerns of Salmonella contamination.
Reverse engineering ketamine's effects may lead to new antidepressants
Weill Cornell Medicine investigators have "reverse engineered" ketamine's antidepressant effects to identify potential new strategies for treating depression. While there are many effective treatments available for depression, not all patients respond to them.
Battery-free skin-conformal wearable system can measure electrocardiogram signals
A research team led by Prof. Jerald Yoo from the Department of Electrical and Computer Engineering at Seoul National University (SNU) has developed a skin-conformal wearable health care system, "SkinECG," capable of measuring electrocardiogram (ECG) signals without a battery. By combining energy harvesting with human body–coupled power transfer, the study presents a new solution to one of the most critical challenges in wearable devices: power supply.

Protective microglia subtype offers potential therapeutic pathway in Alzheimer’s disease

Recent Posts

JUST IN